LeMaitre Vascular Inc.
LMAT | NASDAQ
$79.20
+$0.33 (+0.42%)
At close: Sep 21, 2026, 4:00 PM ET
$79.20
$0 (0.00%)
Pre-market:
Sep 22, 2026, 5:55 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 249.6M | 219.86M | 193.48M | 161.65M | 154.42M | 129.37M |
Cost of Revenue | 71.06M | 68.96M | 66.44M | 56.76M | 53.04M | 44.75M |
Gross Profit | 178.54M | 150.9M | 127.05M | 104.9M | 101.38M | 84.62M |
Operating Income | 67.91M | 52.26M | 36.71M | 26.83M | 36.43M | 28.79M |
Interest Income | 13.09M | 4.95M | 3.08M | 986K | 197K | 207K |
Pretax Income | 75.18M | 56.88M | 39.48M | 27.49M | 34.29M | 27.36M |
Net Income | 57.73M | 44.04M | 30.11M | 20.64M | 26.91M | 21.22M |
Selling & General & Admin | 96.49M | 83M | 72.89M | 61.67M | 53.16M | 46.2M |
Research & Development | 14.14M | 15.65M | 16.97M | 13.29M | 11.8M | 10.1M |
Other Expenses | n/a | n/a | 485K | 3.11M | n/a | -470K |
Operating Expenses | 110.63M | 98.65M | 90.34M | 78.07M | 64.96M | 55.83M |
Interest Expense | 5.18M | 205K | n/a | n/a | 2.22M | 1.31M |
Selling & Marketing Expenses | 54.46M | 46.74M | 41.05M | 32.92M | 27.66M | 23.7M |
Cost & Expenses | 181.69M | 167.61M | 156.77M | 134.82M | 118M | 100.58M |
Income Tax Expense | 17.45M | 12.84M | 9.37M | 6.85M | 7.38M | 6.14M |
Shares Outstanding (Basic) | 22.64M | 22.45M | 22.22M | 21.98M | 21.16M | 20.25M |
Shares Outstanding (Diluted) | 22.93M | 22.78M | 22.42M | 22.17M | 21.48M | 20.48M |
EPS (Basic) | 2.55 | 1.96 | 1.36 | 0.94 | 1.27 | 1.05 |
EPS (Diluted) | 2.52 | 1.93 | 1.34 | 0.93 | 1.25 | 1.04 |
EBITDA | 90.79M | 66.75M | 48.99M | 36.92M | 45.98M | 36.89M |
EBIT | 80.37M | 57.08M | 39.48M | 27.49M | 36.51M | 28.67M |
Depreciation & Amortization | 10.42M | 9.67M | 9.52M | 9.43M | 9.48M | 8.22M |
Add to Watchlist
Select watchlists to add or remove LMAT